Stage 4 Lung Cancer Survivor Joins Rare Trial in Houston

Lorie Young's ultra-rare lung cancer mutation qualified her for a targeted therapy clinical trial that's giving hope to patients with genetic abnormalities.

Her story reveals how personalized cancer treatment is transforming what's possible for advanced-stage patients.